Skip to main content

Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients Cover

.blurhash-client-img { display: none !important; }

Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients

Endocrine Regulations

Volume 56 (2022): Issue 4 (October 2022)

By: Suleyman Baldane, M Celik, Levent Kebapcilar, Suleyman Hilmi Ipekci, Sedat Abusoglu, Huseyin Yilmaz and Husnu Alptekin

Open Access

|Oct 2022

Download the full article as a PDF file.

Articles in this issue

DOI: https://doi.org/10.2478/enr-2022-0028 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 265 - 270

Published online: Oct 20, 2022

Published in print: Oct 1, 2022

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Keywords:

Cushing’s syndrome,

dexamethasone suppression test

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2022 Suleyman Baldane, M Celik, Levent Kebapcilar, Suleyman Hilmi Ipekci, Sedat Abusoglu, Huseyin Yilmaz, Husnu Alptekin, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 56 (2022): Issue 4 (October 2022)

Previous article